GenoFocus Inc (187420) — Cash Flow-to-Debt Ratio
GenoFocus Inc (187420) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of ₩288.09 Million could theoretically repay 0% of its total liabilities (₩81.08 Billion) in one year. See 187420 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GenoFocus Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for GenoFocus Inc across 12 annual periods. Also explore GenoFocus Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GenoFocus Inc (2014–2025)
Year-by-year debt coverage analysis for GenoFocus Inc. For market capitalisation and broader financial context, see 187420 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩3.50 Billion | ₩81.08 Billion | ▲ +84.4% |
| 2024 | 0.02x | ₩2.87 Billion | ₩122.49 Billion | ▲ +134.8% |
| 2023 | -0.07x | ₩-4.82 Billion | ₩71.50 Billion | ▼ -57.3% |
| 2022 | -0.04x | ₩-4.71 Billion | ₩110.02 Billion | ▼ -49.1% |
| 2021 | -0.03x | ₩-2.39 Billion | ₩83.24 Billion | ▲ +14.0% |
| 2020 | -0.03x | ₩-2.45 Billion | ₩73.46 Billion | ▼ -659.0% |
| 2019 | 0.00x | ₩-167.50 Million | ₩38.08 Billion | ▼ -102.8% |
| 2018 | 0.15x | ₩1.56 Billion | ₩10.12 Billion | ▼ -32.8% |
| 2017 | 0.23x | ₩1.36 Billion | ₩5.93 Billion | ▼ -68.4% |
| 2016 | 0.73x | ₩516.09 Million | ₩709.87 Million | ▼ -81.2% |
| 2015 | 3.88x | ₩2.85 Billion | ₩736.18 Million | ▲ +9952.7% |
| 2014 | -0.04x | ₩-286.45 Million | ₩7.28 Billion | — |